Literature DB >> 9870402

Determination of bupivacaine and three of its metabolites in rat urine by capillary electrophoresis.

M A Schieferecke1, K J McLaughlin, A A Faibushevich, C E Lunte.   

Abstract

A capillary electrophoretic (CE) method for the analysis of urinary extracts of the local anesthetic, bupivacaine, and its three main metabolites, desbutylbupivacaine, 3'-hydroxybupivacaine, and 4'-hydroxybupivacaine, in rat urine has been developed. The limits of detection were 0.22 microM for desbutylbupivacaine and bupivacaine, 0.15 microM for 3'-hydroxybupivacaine, and 0.16 microM for 4'-hydroxybupivacaine. The linear range was from 0.7 microM to 16.8 microM for all four compounds. Migration time and peak height reproducibilities, and extraction efficiencies were determined for all four compounds. Peak height reproducibilities (n = 5) for the overall method were improved through the use of prilocaine as an internal standard. Peak height reproducibilities were 5.6% RSD for desbutylbupivacaine and bupivacaine, and 9.9% RSD for 3'-hydroxybupivacaine and 4'-hydroxybupivacaine. Migration time reproducibilities (n = 5) were 2.4% for all compounds. Urine samples were collected from rats administered therapeutic doses of bupivacaine and extracted using a solid-phase extraction method (SPE). Separation of bupivacaine and its metabolites was achieved in 15 min.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870402      PMCID: PMC2519794          DOI: 10.1002/elps.1150191633

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  18 in total

1.  High-performance liquid chromatographic method for the quantitation of bupivacaine, 2,6-pipecoloxylidide and 4'-hydroxybupivacaine in plasma and urine.

Authors:  H Kastrissios; M F Hung; E J Triggs
Journal:  J Chromatogr       Date:  1992-05-20

2.  Capillary electrophoresis of urinary porphyrins with absorbance and fluorescence detection.

Authors:  R Weinberger; E Sapp; S Moring
Journal:  J Chromatogr       Date:  1990-09-07

3.  Isolation and identification by mass spectrometry of metaboltes of bupivacaine.

Authors:  R Bouché; G Lhoest
Journal:  Pharm Acta Helv       Date:  1976

4.  Sensitive determination of bupivacaine in human plasma by high-performance liquid chromatography.

Authors:  H C Michaelis; W P Geng; G F Kahl; H Foth
Journal:  J Chromatogr       Date:  1990-04-27

5.  Simple, rapid high-performance liquid chromatographic determination of bupivacaine in human plasma.

Authors:  N W Sullivan; L Weiner
Journal:  J Chromatogr       Date:  1987-06-05

6.  Simultaneous determination of bupivacaine and its two metabolites, desbutyl- and 4'-hydroxybupivacaine, in human serum and urine.

Authors:  R L Lindberg; J H Kanto; K K Pihlajamäki
Journal:  J Chromatogr       Date:  1986-12-19

7.  Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey.

Authors:  T J Goehl; J B Davenport; M J Stanley
Journal:  Xenobiotica       Date:  1973-12       Impact factor: 1.908

8.  Extradural administration of bupivacaine: pharmacokinetics and metabolism in pregnant and non-pregnant women.

Authors:  K Pihlajamäki; J Kanto; R Lindberg; M Karanko; P Kiilholma
Journal:  Br J Anaesth       Date:  1990-05       Impact factor: 9.166

Review 9.  Clinical pharmacokinetics of epidural and spinal anaesthesia.

Authors:  A G Burm
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

10.  The use of a selected ion monitoring technique to study the disposition of bupivacaine in mother, fetus, and neonate following epidural anesthesia for cesarean section.

Authors:  P M Kuhnert; B R Kuhnert; J M Stitts; T L Gross
Journal:  Anesthesiology       Date:  1981-12       Impact factor: 7.892

View more
  1 in total

1.  Determination of bupivacaine and metabolites in rat urine using capillary electrophoresis with mass spectrometric detection.

Authors:  Ryan M Krisko; Mark A Schieferecke; Todd D Williams; Craig E Lunte
Journal:  Electrophoresis       Date:  2003-07       Impact factor: 3.535

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.